Published in Gene Therapy Weekly, December 13th, 2001
Biomolecular nanomachines have a long way to go before they become practical, but they may one day find uses in screening libraries of DNA sequences, or even inside cells, where they could monitor conditions and synthesize drugs.
Computers whose input and output are strands of DNA have been devised before, but they have always required a laborious series of reactions, each needing human supervision. The automaton developed by Ehud Shapiro, of the Weizmann Institute, Rehovot, Israel, and colleagues requires...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.